Silence Therapeutics PLC (LSE:SLN) - Share price


Stock Report

Silence Therapeutics PLC SLN

Last Price
GBX455.00

Day Change
-7.00|-1.52%

As of 22/05/2020
16:35:29 BST | GBX
Minimum 15 Minutes Delay.

Last Close462.00p
Day Range442.00 - 474.00
Mkt Cap376.70Mil
52-Wk Range42.00 - 646.50
Yield %-
ISINGB00B9GTXM62
Volume45,382
P/E-
P/S14.00
P/CF1.98

Share Price

Total Returns 22/05/2020

 Chg (%)  
More ...
Silence Therapeutics PLC6.81 
FTSE 100 TR GBP4.33
 
Financials
201720182019
More ...
Income Statement
Turnover0.020.000.24
Operating Profit-14.39-20.57-22.73
Net Profit-1.62-18.41-19.58
Reported EPS-2.30-26.20-26.10
Balance Sheet
Current Assets45.5529.5037.47
Non Current Assets9.469.398.61
Total Assets55.0138.8946.08
Current Liabilities2.663.839.65
Total Liabilities---
Total Equity52.3535.0620.91
Cash Flow
Operating Cash Flow-11.61-18.57-0.58
Net Change in Cash3.46-21.25-8.02
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
10/10/2019PurchaseMr. David Jakob Lemus186.004,0007,440.00
10/10/2019Exercise of OptionMr. David Jakob Lemus5.001,62681.00
07/10/2019Exercise of OptionMr. Alistair William Gray5.001,62681.00
02/10/2019PurchaseMr. Alistair William Gray189.003,1715,993.00

Company Profile

Silence Therapeutics PLC is a biotechnology company in the United Kingdom. It uses its RNA technology to develop drugs to address genetic disorders.

Sector

Biotechnology

Index

FTSE AIM UK 50 ,FTSE AIM 100 ,FTSE AIM All-Share

Next Event 09/06/2020

Annual General Meeting
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-62.70
Op Mrgn-93.17
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Executive Director, ChairmanMr. Iain Gladstone Ross
Non-Executive DirectorMr. Alistair William Gray
Executive DirectorDr. Giles Victor Campion
Non-Executive DirectorDr. Steven Joseph Romano
Non-Executive DirectorMr. David Jakob Lemus
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.